Skip to content

Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00500695
Enrollment
98
Registered
2007-07-13
Start date
2006-05-31
Completion date
2013-10-31
Last updated
2017-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizoaffective Disorder, Schizophrenia

Brief summary

This project will assess the utility of a brief motivational intervention to engage smokers with schizophrenia in treatment for tobacco dependence treatment. It is hypothesized that a brief motivational intervention will be more effective in engaging smokers with schizophrenia to tobacco dependence treatment than an educational intervention. The educational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by teaching subjects about the negative effects of smoking and the success of tobacco dependence treatment. The motivational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by increasing subjects' motivation to change by presenting objective and personalized information regarding their smoking behaviors in a non-judgmental and supportive manner.

Detailed description

See Brief Summary above.

Interventions

BEHAVIORALMotivational Interviewing

Motivational Interviewing

BEHAVIORALPsychoeducation

Psychoeducation

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Current smokers must be over the age of 18, * Must have a diagnosis of schizophrenia or schizoaffective disorder * Must smoke at least 10 cigarettes per day * Must be capable of giving informed consent as measured by Folstein Mini Mental Status Exam of at least 22

Exclusion criteria

•Those unable to give informed consent.

Design outcomes

Primary

MeasureTime frame
Attendance at first smoking cessation sessionone month

Secondary

MeasureTime frame
Cigarettes per day1-Month Follow Up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026